NuCana (NCNA) Retained Earnings (2015 - 2025)

NuCana (NCNA) reported Retained Earnings of $115.8 million for Q4 2025, up 15.07% on a YoY basis from $100.7 million in Q4 2024, and down 0.88% sequentially from $116.9 million in Q3 2025.

NuCana (NCNA) Retained Earnings (2015 - 2025) Analysis & Trends

NuCana (NCNA) has 11 years of Retained Earnings data on file, last reported at $115.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 15.07% year-over-year to $115.8 million; the trailing twelve-month figure through Dec 2025 stood at $115.8 million (up 15.07% YoY), and the FY2025 full-year result was $114.8 million, up 14.53% from the prior year.
  • Retained Earnings fell to $115.8 million in Q4 2025, from $116.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $116.9 million in Q3 2025 to a low of $88.5 million in Q3 2022.
  • A 5-year average of $99.6 million and a median of $98.4 million in 2022 frame the typical range for Retained Earnings.
  • Across the five-year window, Retained Earnings advanced 21.06% in 2021 and retreated 8.84% in 2022, its largest moves.
  • Tracing NCNA's Retained Earnings over 5 years: stood at $97.2 million in 2021, then declined by 8.48% to $89.0 million in 2022, then advanced by 10.42% to $98.3 million in 2023, then grew by 2.43% to $100.7 million in 2024, then advanced by 15.07% to $115.8 million in 2025.
  • Business Quant data shows NCNA's Retained Earnings at $115.8 million in Q4 2025, $116.9 million in Q3 2025, and $115.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -24.89 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 115.82 Mn
Sep 30, 2025 116.85 Mn
Jun 30, 2025 115.27 Mn
Mar 31, 2025 99.01 Mn
Dec 31, 2024 100.65 Mn
Sep 30, 2024 101.87 Mn
Jun 30, 2024 98.92 Mn
Mar 31, 2024 101.02 Mn
Dec 31, 2023 98.27 Mn
Sep 30, 2023 99.35 Mn
Jun 30, 2023 97.24 Mn
Mar 31, 2023 93.48 Mn
Dec 31, 2022 88.99 Mn
Sep 30, 2022 88.47 Mn
Jun 30, 2022 94.00 Mn
Mar 31, 2022 98.60 Mn
Dec 31, 2021 97.24 Mn
Sep 30, 2021 97.05 Mn
Jun 30, 2021 96.74 Mn
Mar 31, 2021 93.04 Mn